JPRN-UMIN000044356招募中未知
The effect of brolucizumab on age-related macular degeneration - The effect of brolucizumab on AMD
Department of Ophthalmology, Juntendo University Faculty of Medicine0 个研究点目标入组 50 人开始时间: 2022年6月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Those who are judged by the principal investigator to be inappropriate as research subjects. Those who are judged to have difficulty in going to the hospital on a regular basis. Those who have an intra-ocular inflammation.
研究者
相似试验
Unknown
不适用
BEOVU Versus Eylea in the Treatment of Age-related Macular Neovascular DegenerationMacula Lutea DegenerationNCT04882956Benha University40
终止
4 期
Intravitreal Brolucizumab in Neovascular Age-related Macular Degeneration With Limited Response to AfliberceptNeovascular Age-related Macular DegenerationNCT04287348Vista Klinik16
招募中
不适用
Efficacy of brolucizumab on AMD in patients exhibiting aflibercept resistanceAMDJPRN-UMIN000044180agoya University50
Unknown
3 期
BEOVU Versus Eylea in the Treatment of Diabetic Macular EdemaMacular EdemaNCT04955171Benha University60
Unknown
4 期
BEOVU in the Treatment of Dystrophy-related Macular Neovascular DegenerationDystrophy, RetinalNCT04690062Benha University20